Surveys of patients suggest many want to be actively involved in treatment decisions for acute coronary syndromes. However, patient experiences of their engagement and participation in early phase decision-making have not been well described.
We performed a patient led qualitative study to explore patient experiences with decision-making processes when admitted to hospital with non-ST elevation acute coronary syndrome. Trained patient-researchers conducted the study via a three-phase approach using focus groups and semi-structured interviews and employing grounded theory methodology.
Twenty patients discharged within one year of a non-ST elevation acute coronary syndrome participated in the study. Several common themes emerged. First, patients characterized the admission and early treatment of ACS as a rapidly unfolding process where they had little control. Participants felt they played a passive role in early phase decision-making. Furthermore, participants described feeling reduced capacity for decision-making owing to fear and mental stress from acute illness, and therefore most but not all participants were relieved that expert clinicians made decisions for them. Finally, once past the emergent phase of care, participants wanted to retake a more active role in their treatment and follow-up plans.
Patients admitted with ACS often do not take an active role in initial clinical decisions, and are satisfied to allow the medical team to direct early phase care. These results provide important insight relevant to designing patient-centered interventions in ACS and other urgent care situations.
Similar content being viewed by others
Acute coronary syndrome (ACS) is a major cause of mortality and morbidity in Canada, with in-hospital mortality in up to 5% of patients . Non-ST elevation ACS can be managed using either an invasive approach (involving use of coronary angiography and percutaneous coronary intervention and/or cardiac surgery for revascularization) or a conservative approach (employing medical therapies and reserving invasive procedures only for people with signs of ongoing cardiac ischemia despite medical management). Randomized trials show early invasive management reduces the risk of recurrent myocardial infarction, re-hospitalization, and improves long-term survival in appropriately selected high-risk individuals compared with conservative management for ACS [2,3,4,5,6]. Accordingly, current guidelines recommend early invasive management for high-risk individuals with ACS . However, for those patients not considered to be high-risk, the optimal time to proceed to invasive management and re-vascularization or persist with medical therapy is uncertain [6, 8]. This decision point has implications for patient outcomes such as mortality, bleeding and kidney injury events, as well as for health care system costs.
The patient’s role in treatment decisions in the setting of ACS has recently begun to receive more attention. Krumholz et al. conducted a survey of 6636 patients from the United states 24 to 72 h after admission for an acute myocardial infarction (MI) and found a majority of patients wanted an active role in their treatment decisions . Another study found that while most patients did not want to make treatment decisions themselves, the vast majority wanted their preferences to be taken into account by their physician . However, the patient’s capacity to make decisions in the emergency setting may preclude them from actively participating in treatment decisions and, in such cases, patients have been found to be more willing to defer decisions entirely to their physicians .
Patient targeted decision aids are widely used in outpatient and ambulatory settings to support patients in medical decision-making . However, little research has been conducted into patient perspectives on their engagement in the early decision-making processes for ACS. This qualitative study was designed to explore the experiences of patients on their participation in the decision making process for early non-ST elevation ACS care, and further explored patient perspectives on potential use of decision aids when admitted to hospital with ACS.
We used methods previously reported by the Patient and Community Engagement Research (PaCER) program . The PaCER methodology is based on grounded theory, whereby qualitative data is collected iteratively, analyzed for themes, and used to plan subsequent phases of the research process through the use of trained patient researchers. This theoretical approach relies on the underlying concept of generating new theory as data are collected, as opposed to collecting data to test an existing theory [13,14,15].
Patient-researchers –patient and community engagement researchers (PaCERs)
Data collection and analysis were performed by four trained PaCERs. The two lead PaCERs (JM, ST) had a history of chronic disease and completed the formal PaCER internship in patient engagement research methods and the grounded theory framework, and had conducted previous projects using these methods . They were supported by an additional two PaCERs with personal experiences with heart disease and training in patient engagement (WP, CP). Oversight at each phase was provided by PaCER and APPROACH faculty.
Potential study participants were identified from the Alberta Provincial Project for Outcome Assessment of Coronary Heart Disease (APPROACH) registry . We used purposive sampling to ensure the study represented a broad range of ACS patient ages and was approximately balanced by sex. Inclusion criteria were hospitalization with non-ST elevation ACS within the last year, fluency in English, residency in the local area, and having previously provided informed consent to be contacted for research purposes.
The Set, co-design phase consisted of a single focus group of ACS patients. Participants were asked to share their positive and negative experiences with their last hospitalization for ACS and how the treatment they received unfolded to explore the scope of responses, language used and choice and modification of data collection. In addition, participants were asked what could have made for a better experience. Discussion points were documented on flip chart pages and the session was recorded.
Based on findings during the Set, co-design phase, the Collect phase consisted of a focus group followed by individual interviews. Participants in the focus group were asked to speak about the treatment decision-making process and their awareness of, and interest in being involved in treatment options. In addition, the participants explored the idea of being provided with a decision aid tool to help involve them in the decision-making process.
The interview guide to be used for individual interviews was informed by the analysis of audiotape and focus group notes. Interviews were conducted in pairs with one lead patient researcher accompanied by one of two patient researchers with a history of heart disease. Individual interviews were conducted with ACS patients not involved with the Set phase focus groups.
Data about the clinical presentation, risk factor profile, and in-hospital management were extracted from the APPROACH database. In APPROACH, the classification of ACS represents the attending physician’s final discharge diagnosis.
Audiotapes and interviewer’s notes from each interview were used to create a descriptive document, which was analyzed independently by two PaCERs. Each stage of data collection was coded to explore points that spoke to decision-making and value of a decision aid. The researchers compared and contrasted their points and through a collaborative process five categories were identified: 1) awareness of treatment decisions; 2) interest in being more involved in treatment decisions; 3) information they were given; 4) interest in more information about treatment options; and 5) perceived value of a decision aid tool.
The five categories identified in the Collect phase were taken to the Reflect focus group, which consisted of participants from either the Set or Collect phase. During this phase, participants collaborated around the data analysis and reflected on the fit between what they had said and what was reported. In addition, some information was explored in more detail and recommendations were developed. The focus group ended with a reflection on what they were taking away from their involvement in the study.
No further focus groups or interviews were planned once the research team was confident saturation had been reached and no new themes were emerging from further patient interviews and focus groups.
The funding source did not have a role in this study.
Of 75 eligible patients identified from the APPROACH database and approached, 20 agreed to participate in the study. Their characteristics are described in Table 1. The median age of participants was 68.5 years, 60% were men, 70% were hospitalized with a non-ST elevation myocardial infarction, all received cardiac catheterization and 55% went on to receive percutaneous or surgical revascularization.
The following themes regarding experiences from their hospital admission and the decision-making process for ACS treatment were identified from participants.
Perception of the emergency hospital admission
Participant stories of their hospitalization experience with ACS began with the onset of their symptoms and subsequent arrival at the emergency department and admission to hospital. They found themselves in an unexpected and potentially life-threatening situation and in some cases an outright crisis. They were shocked, scared, and felt out of control. Participants also recounted how quickly events unfolded once they arrived at the hospital (Table 2).
Patients’ views on involvement in ACS treatment decision-making on emergency hospital admission
Participants felt they had not been involved in making treatment decisions when admitted to hospital and they were often unaware of different treatment options. Patients acknowledged that as specialists in their field, cardiologists were in the best position to make treatment decisions. Participants described that once cardiologists had considered the options and selected the treatment that was best for them, the recommendation would be presented to them and they were given the opportunity to consent to the recommended treatment. On reflection they thought this approach was understandable given the life-threatening nature of their illness. However, patients felt treatment decisions were made for them rather than with them (Table 3).
Feeling incapable of participating in decision-making
Study participants thought that given the stressful life-threatening situation in which they found themselves, they would not have been capable of participating in complex decision-making. In this situation they relied on someone else to make the decisions. Realizing that decisions had to be made quickly, they put their trust in the cardiologists (Table 4).
Relinquishing control to experts in a presumed emergency
Participant’s were comfortable with their cardiologists making treatment decisions and were willing to turn their decisions over to the experts. In fact, many participants felt this should be the normal course of action. Patients relied on the cardiologists’ expertise and experience, putting their trust in them (Table 5).
Potential role of a patient-targeted decision aid to support ACS treatment decision-making
Patients were asked to reflect on the potential role of a decision aid to support their engagement in decision-making when admitted to hospital with ACS. The predominant view was that given the life-threatening situation and their mental and emotional state, such a tool would not have been helpful in the initial phase of their admission. However, some participants voiced a different perspective that this may be helpful, particularly once past the initial acute phase of care, or when involving other care providers or family members in treatment decisions. These patients felt an individualized shared decision-making tool would begin to address their specific information needs and would promote collaborative decision-making. The tool would also help them absorb all they needed to know before they went home and guide them on what specific questions to ask in their follow-up medical appointments (Table 6).
In this qualitative study, participants who had been recently hospitalized with an ACS described the emotional shock and loss of control that accompanied their event, yet reported generally positive experiences with their care. Importantly, with respect to their role in decision-making, the majority of participants were unaware of the decision to pursue an early invasive versus medical management approach to treatment of their ACS, and did not describe being involved in this decision. Participants acknowledged that decisions were largely made for them rather than with them during their care, yet felt this was appropriate given the circumstances. Most participants were grateful that important decisions had been made for them, as they felt they would not have been able to make sound decisions in the early acute phase of their admission. Some participants expressed a need for health professionals to better understand their individual circumstances; provide more explanation about what lay ahead, and clearer explanations about their treatment, particularly later in their admission. These findings identify important themes that are relevant when considering strategies to engage patients in decision making for ACS care.
Little research has been conducted into the involvement of patients in the decision-making process during the initial admission period of an acute illness. A recent qualitative study found that patients faced with decision-making in the emergency department felt unbearable pressure and a compromised ability to absorb new information. In these situations patients were able to relieve this pressure by placing their trust in the healthcare provider and transferring the decision to them.  For the most part, the patients in our study were relieved that specialized professionals stepped in and made the decisions in the acute setting. Similar to other research, the findings of our study are likely explained by the life-threating nature of ACS events that leave patients mentally and emotionally unable to participate in complex decision-making.
The study’s findings also suggest that the extent to which patients want to be involved in decision-making is likely to vary, with some wanting more involvement than others. Wang et al. found that the extent to which patients want to be involved in decision-making is related to previous experience or a priori knowledge of their health condition , in addition to their level of acuity. During the emergency stages of ACS admission, most patients felt there would be limited benefit from patient-targeted decision aids. This suggests that ACS decision support tools, for example to help tailor the management approach to patient risk, are likely best targeted to clinicians rather than patients. Other studies have suggested shared decision-making can be an effective strategy in emergency care. A systematic review of fives studies on engaging patients in shared decision-making in the emergency setting reported positive results for the use of decision support interventions targeted at patients and patient surrogates, improvements in patient or surrogate engagement in decision-making, patient knowledge and satisfaction of care. This review suggested a positive impact of eliciting patient preferences and values towards treatment options in emergency care, and suggests a potential role for patient involvement in decision-making may remain in ACS care (17). This may be most valuable once patients are past the crisis situation, which is when participants in our study showed the most interest for greater involvement in decision-making. In addition, this is where they expressed the greatest interest in tools that could address their personal values related to the potential harms and benefits of treatment choices, including their medications. Such tools could be tailored to their individual circumstances and would support their learning in the non-emergency hospitalization phase and beyond.
Participants in our study were interested in more information on their medication management before being discharged from hospital, including how each medication will benefit them. Improving delivery of this information to patients may help engage them in secondary prevention of cardiovascular disease. This is similar to findings from qualitative research in patients’ perspectives of care for osteoarthritis, where patients expressed a need for specific self-management strategies that align with the stages of OA severity, along with specific information about when they should seek further help . Together these studies suggest the information patients typically receive may not be at the level of specificity they require.
Limitations of this study include the small sample size common to qualitative studies of this nature. The sample is within the expected range for saturation in grounded theory studies. While we continued to recruit patients until thematic saturation was reached, the generalizability of the results to other ACS patients and care settings is unknown. Importantly, all patients received an invasive management approach for ACS and were at high risk for adverse outcomes based on their admission characteristics. This may have made physicians more confident in treatment recommendations and reduced the need to engage patients in treatment decisions. In addition, our sampling strategy did not select patients based on clinical outcomes after discharge. Though participants had a variety of demographic and clinical characteristics, and differed in their initial presentation and management, additional themes may have emerged if our sample included patients having experienced more adverse outcomes. It is possible that a critical case analysis would have revealed that such patients had different perceptions of decision-making in the initial phase of their ACS care than those with positive outcomes. We lacked follow-up clinical data to perform such an analysis. Our findings may not be generalizable to patients treated conservatively or in scenarios where there is less certainty about the benefits versus risk of an invasive versus conservative management approach. In addition, recruitment for this study was focused on patients themselves and did not include family members who are often key advocates when patients are unable to participate in decision-making.
In conclusion, we used a grounded theory approach to engage patients to share their views on their hospital admission, subsequent decision-making process, and the potential role for a decision aid in ACS care. We found that most patients did not feel they had taken an active role in initial care decisions, instead allowing the medical team to direct early phase care. Importantly, in general our patients did not feel capable of participating actively in decision-making early in their presentation, and were confident in decisions taken by the medical team during the emergency phase of care. Although patients felt that a patient-targeted decision aid may not be useful during the initial period of emergency admission, they felt such tools may be beneficial once they have stabilized, have the ability to participate in treatment decisions and can use the tool to tailor their treatment choices in the non-emergency hospitalization phase and subsequent discharge.
Acute Coronary Syndrome
Alberta Provincial Project for Outcome Assessment of Coronary Heart Disease
Patient and Community Engagement Research program
Patient and Community Engagement Researchers
Wang JY, et al. Cardiovascular risk factors and in-hospital mortality in acute coronary syndromes: insights from the Canadian global registry of acute coronary events. Can J Cardiol. 2015;31(12):1455–61.
Ragmin F, Fast Revascularisation I. During InStability in coronary artery disease, invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet. 1999;354(9180):708–15.
Cannon CP, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344(25):1879–87.
Fox KA, et al. 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet. 2005;366(9489):914–20.
Lagerqvist B, et al. FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease. Heart. 2005;91(8):1047–52.
Fanning JP, et al. Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era. Cochrane Database Syst Rev. 2016;5:CD004815.
Amsterdam EA, et al. The 2014 American College of Cardiology ACC/American Heart Association guideline for the management of patients with non-ST-elevation acute coronary syndromes: ten contemporary recommendations to aid clinicians in optimizing patient outcomes. Clin Cardiol. 2015;38(2):121–3.
Mehta SR, et al. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med. 2009;360(21):2165–75.
Krumholz HM, et al. Decision-making preferences among patients with an acute myocardial infarction. JAMA Intern Med. 2013;173(13):1252–7.
Bowling A, et al. What do patients really want? Patients’ preferences for treatment for angina. Health Expect. 2008;11(2):137–47.
Wang LH, et al. The emergency patient's participation in medical decision-making. J Clin Nurs. 2016;25(17–18):2550–8.
Stacey D, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014;1:CD001431.
Marlett N, et al. Building new roles and relationships in research: a model of patient engagement research. Qual Life Res. 2015;24(5):1057–67.
Marlett NJ, Emes C, Jennett P. Grey matters : a guide to collaborative research with seniors. Calgary: University of Calgary Press; 2010. xviii, 325 p
Oktay JS. Grounded theory. In: Pocket guides to social work research methods. Oxford New York: Oxford University Press; 2012. xiv, 173 p.
Ghali WA, Knudtson ML. Overview of the Alberta provincial project for outcome assessment in coronary heart disease. On behalf of the APPROACH investigators. Can J Cardiol. 2000;16(10):1225–30.
Miller JL, et al. Support for living a meaningful life with osteoarthritis: a patient-to-patient research study. Patient. 2016;9(5):457–64.
Gill M, et al. Patient and family member-led research in the intensive care unit: a novel approach to patient-centered research. PLoS One. 2016;11(8):e0160947.
Financial support for this study was provided in part by an unrestricted grant from Alberta Health Services Cardiovascular and Stroke Strategic Clinical Network and by APPROACH. APPROACH was initiated with a grant from The W Garfield Weston Foundation and is currently funded by Alberta Health Services, Mazankowski Heart Institute and the Libin Cardiovascular Institute of Alberta. The funding agreement ensured the authors’ independence in designing the study, interpreting the data, writing, and publishing the report.
Availability of data and materials
The datasets generated and/or analysed during the current study are not publicly available due to their nature - audio files and transcripts that may contain personally identifiable information. Summary files are available from the corresponding author on reasonable request.
Ethics approval and consent to participate
This research has been approved by the University of Calgary Conjoint Health Research Ethics Board: (CHREB Ethics ID: 14–1192). All patients provided written consent for study participation.
Consent for publication
As part of the consent process, patients and clinicians gave specific written consent to have the content of interviews and focus groups published without any identifying details.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Wilson, T., Miller, J., Teare, S. et al. Patient perspectives on engagement in decision-making in early management of non-ST elevation acute coronary syndrome: a qualitative study. BMC Med Inform Decis Mak 17, 153 (2017). https://doi.org/10.1186/s12911-017-0555-9